B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells

Published:2010-09-09 Issue:11 Volume:24 Page:1885-1892
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Gross E,L’Faqihi-Olive F-E,Ysebaert L,Brassac M,Struski S,Kheirallah S,Fournié J-J,Laurent G,Quillet-Mary A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010176.pdf

Reference38 articles.

1. Montserrat E . Further progress in CLL therapy. Blood 2008; 112: 924–925.

2. Dighiero G, Hamblin TJ . Chronic lymphocytic leukaemia. Lancet 2008; 371: 1017–1029.

3. Castro JE, Sandoval-Sus J, Bole J, Rassenti L, Kipps TJ . Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia. Leukemia 2008; 22: 2048–2053.

4. Byrd JC, Lin TS, Grever MR . Treatment of relapsed chronic lymphocytic leukemia: old and new therapies. Semin Oncol 2006; 33: 210–219.

5. Olsson A, Norberg M, Okvist A, Derkow K, Choudhury A, Tobin G et al. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer 2007; 97: 769–777.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cells in esophageal squamous cell carcinoma;Pathology - Research and Practice;2022-09

2. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer;Cells;2020-06-17

3. Cancer stem cells in esophageal squamous cell cancer (Review);Oncology Letters;2019-09-20

4. Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling;Blood Advances;2018-04-18

5. Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment;Blood Cancer Journal;2016-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3